CareLit Fachartikel
Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review
E Beck, A Kaplan, JM Fitzgerald, GE Azzi, M Engel, R Buhl · Pneumologie · 2019 · Heft S 01 S 01
Dokument
1194728
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review
Schlagworte
Asthma
Pneumologie